Literature DB >> 25896586

[Inverse psoriasis].

P Weisenseel1, K Reich.   

Abstract

Inverse psoriasis is clinically defined by chronic inflammatory lesions in intertrigineous areas. Colonisation or infection with Candida ssp. or bacteria is common. The disease-related quality of life is significantly reduced especially regarding sexual behavior. After the exclusion of relevant differential diagnoses, therapy should be adapted to the clinical outcome and potential comorbidities. Substances which are efficacious in psoriasis vulgaris are generally efficacious in inverse psoriasis, but have to be used off-label. Controlled clinical studies are only available for topical ascomycin.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25896586     DOI: 10.1007/s00105-015-3628-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  18 in total

1.  Inverse psoriasis: case presentation and review.

Authors:  Zain U Syed; Amor Khachemoune
Journal:  Am J Clin Dermatol       Date:  2011-04-01       Impact factor: 7.403

2.  Treatment of inverse psoriasis with excimer therapy and tacrolimus ointment.

Authors:  José Manuel Carrascosa; Xavier Soria; Helena Domingo; Carlos Ferrándiz
Journal:  Dermatol Surg       Date:  2007-03       Impact factor: 3.398

3.  Use of Topical Coal Tar Foam for the Treatment of Psoriasis in Difficult-to-treat Areas.

Authors:  Joshua A Zeichner
Journal:  J Clin Aesthet Dermatol       Date:  2010-09

4.  Psoriasis in the elderly: epidemiological and clinical aspects, and evaluation of patients with very late onset psoriasis.

Authors:  C Phan; M-L Sigal; E Estève; Z Reguiai; H Barthélémy; N Beneton; F Maccari; M Lahfa; D Thomas-Beaulieu; T Le Guyadec; A Vermersch-Langlin; L Mery-Bossard; V Pallure; M Kemula; B Labeille; A Beauchet; E Mahé
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-11-11       Impact factor: 6.166

5.  Tacrolimus ointment is effective for facial and intertriginous psoriasis.

Authors:  Mark Lebwohl; Amy Krupnick Freeman; M Shane Chapman; Steven R Feldman; Jennifer E Hartle; Alice Henning
Journal:  J Am Acad Dermatol       Date:  2004-11       Impact factor: 11.527

6.  Clinical characterisation at onset of childhood psoriasis - a cross sectional study in Sweden.

Authors:  Josefin Lysell; Mesfin Tessma; Pernilla Nikamo; Carl-Fredrik Wahlgren; Mona Ståhle
Journal:  Acta Derm Venereol       Date:  2015-04       Impact factor: 4.437

7.  Botulinum toxin type-A for the treatment of inverse psoriasis.

Authors:  M Zanchi; F Favot; M Bizzarini; M Piai; M Donini; P Sedona
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-04       Impact factor: 6.166

8.  Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation.

Authors:  Robert E Kalb; Jerry Bagel; Neil J Korman; Mark G Lebwohl; Melodie Young; Elizabeth J Horn; Abby S Van Voorhees
Journal:  J Am Acad Dermatol       Date:  2009-01       Impact factor: 11.527

Review 9.  [The role of streptococci in psoriasis].

Authors:  J C Prinz
Journal:  Hautarzt       Date:  2009-02       Impact factor: 0.751

10.  Inverse psoriasis involving genital skin folds: successful therapy with dapsone.

Authors:  Antonio Guglielmetti; Rodrigo Conlledo; Juliana Bedoya; Francisco Ianiszewski; Julio Correa
Journal:  Dermatol Ther (Heidelb)       Date:  2012-10-09
View more
  1 in total

Review 1.  Inverse Psoriasis: From Diagnosis to Current Treatment Options.

Authors:  Giuseppe Micali; Anna Elisa Verzì; Giorgia Giuffrida; Enrico Panebianco; Maria Letizia Musumeci; Francesco Lacarrubba
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-12-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.